This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone …

Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )Transformed Small Cell Lung Cancer+3 more

~Estimated

~$10 – $7,500

PfizerNCT07476287

Phase 1

Phase I/II Trial of Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer

This open-label, Phase I/II trial is studying the safety and effectiveness of an experimental drug combination, lurbinectedin with osimertinib, against a rare …

Small Cell Lung Cancer ( SCLC )Transformed Small Cell Lung Cancer

~Estimated

~$10 – $7,500

Misty ShieldsNCT07153055